News for November 2014

News Archive

New insights that link Fragile X Syndrome (FXS) and Autism Spectrum Disorders (ASD) New insights that link Fragile X Syndrome (FXS) and Autism Spectrum Disorders (ASD)

Crucial role for FMRP (Fragile X Mental Retardation Protein) in embryonic development of the brain cortex

Charities Pledge to Inject Millions to Jump Start Drug Development for Brain Diseases Charities Pledge to Inject Millions to Jump Start Drug Development for Brain Diseases

MRC Technology to lead Neurodegeneration Medicines Acceleration Programme to uncover promising drugs in pharma libraries

The Current issue of “The view from here” discusses translational medicine. The Current issue of “The view from here” discusses translational medicine.

The topic of this month’s newsletter from Drug Discovery Today is translational medicine.

Patent Box changes require urgent clarification, says Withers & Rogers Patent Box changes require urgent clarification, says Withers & Rogers

Last month, Treasury Minister David Gauke gave a robust defence of the UK's Patent Box scheme, which allows profits from technologies protected by a UK or other qualifying patents to benefit from a lower rate of corporation tax.

Public rank antibiotic resistance as major threat to UK, second only to threat of terrorism Public rank antibiotic resistance as major threat to UK, second only to threat of terrorism

Longitude Prize publishes ‘attitudes to antibiotics’ survey as the challenge opens for entriesPrize backed by Prime Minister David Cameron, Prof Alice Roberts, Lord Martin Rees and Dame Sally DaviesPortrait of Alexander Fleming made from tablet capsules commissioned to mark the Prize opening

Catalyst-Where-You-Want-It Method Expands the Possibilities for New Drug Development Catalyst-Where-You-Want-It Method Expands the Possibilities for New Drug Development

Chemists at The Scripps Research Institute (TSRI) and the Shanghai Institute of Organic Chemistry have described a method for creating and modifying organic compounds that overcomes a major limitation of previous methods. The advance opens up a large number of novel chemical structures for synthesis and evaluation, for example, as candidate pharmaceuticals.

MRC funds new MRI-PET scanner for Imanova/Imperial collaboration to expand Dementias Platform UK (DPUK) clinical infrastructure MRC funds new MRI-PET scanner for Imanova/Imperial collaboration to expand Dementias Platform UK (DPUK) clinical infrastructure

In collaboration with Imperial, Imanova, the world-leading centre for imaging sciences, today announced that they will install a state-of-the-art MRI-PET scanner at their London facility from a MRC Grant for DPUK. The installation marks the start of a concerted effort across seven UK clinical academic research sites to bring benefits of this new technology to doctors studying dementia and to their patients.

UCB calls for greater UK life science collaboration and investment in skills to drive innovation UCB calls for greater UK life science collaboration and investment in skills to drive innovation

UCB calls for further collaboration in the life sciences to enhance drug discovery and help drive economic growth. The PhD Networking Day promotes collaboration between leading UK universities and industry while also providing a platform to share best practice and deliver world class skills training for the next generation of science leaders. MedCity, spirit of collaboration, support for UK life sciences and commercial mind-set was praised by UCB